Does Rallies show Form 4 insider transactions for SURG?

Yes. Rallies tracks SURG insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SURG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SURG. It does not provide personalized investment advice.

SURG (SurgePays, Inc. Common Stock) Stock Analysis - Insider Trades

SurgePays, Inc. Common Stock (SURG) is a publicly traded Technology sector company. As of May 21, 2026, SURG trades at $0.50 with a market cap of $13.28M and a P/E ratio of -0.28. SURG moved -5.29% today. Year to date, SURG is -70.58%; over the trailing twelve months it is -84.27%. Its 52-week range spans $0.46 to $3.47. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces SURG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SURG stock inside the company?

Recent SURG insider activity includes May David Allen bought 28.42K, May David Allen bought 10.00K, May David Allen sold 63.00K, Cox Kevin Brian bought 15.07K, and Cox Kevin Brian sold 35.18K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SURG Key Metrics

Key financial metrics for SURG
Metric	Value
Price	$0.50
Market Cap	$13.28M
P/E Ratio	-0.28
EPS	$-1.80
Dividend Yield	0.00%
52-Week High	$3.47
52-Week Low	$0.46
Volume	0
Avg Volume	0
Revenue (TTM)	$56.96M
Net Income	$-36.07M
Gross Margin	-18.59%

Recent SURG Insider Trades

May David Allen bought 28.42K (~$45.45K) on Dec 10, 2025.
May David Allen bought 10.00K (~$16.20K) on Dec 10, 2025.
May David Allen sold 63.00K (~$177.28K) on Jun 6, 2025.
Cox Kevin Brian bought 15.07K (~$41.45K) on May 16, 2025.
Cox Kevin Brian sold 35.18K (~$64.08K) on Dec 3, 2024.

Latest SURG News

Surgepays Q1 Loss Widens to $11.2M, Cuts Enrollment Costs 48% — May 15, 2026
SurgePays Q1 Revenue Climbs 51% to $16 Million, Subscribers Exceed 200,000 — May 15, 2026
SurgePays Launches Real-Time AI Engine to Boost Subprime Revenue Per User — Apr 21, 2026
Surgepays Cuts Burn to $250K–$300K Monthly After $30.7M 2025 Net Loss — Apr 15, 2026
SurgePays Launches White-Label Stored Value and Loyalty Platform — Apr 2, 2026

SURG Analyst Consensus

2 analysts cover SURG: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.

Common questions about SURG

Who is trading SURG stock inside the company?: Recent SURG insider activity includes May David Allen bought 28.42K, May David Allen bought 10.00K, May David Allen sold 63.00K, Cox Kevin Brian bought 15.07K, and Cox Kevin Brian sold 35.18K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SURG?: Yes. Rallies tracks SURG insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SURG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SURG. It does not provide personalized investment advice.